Stock NBIX NEUROCRINE BIOSCIENCES, INC.
Add to a list

MarketScreener Strategies Neurocrine Biosciences, Inc.

Equities

NBIX

US64125C1099

Pharmaceuticals

Market Closed - Nasdaq
Other stock markets
 01:30:00 23/04/2026 am IST 		5-day change 1st Jan Change
131.18 USD +0.74% Intraday chart for Neurocrine Biosciences, Inc. -0.20% -7.51%
14/04 Neurocrine Biosciences Presents Real-World Claims Analysis Demonstrating Greater Treatment Persistence With INGREZZA Capsules Compared To AUSTEDO XR CI
13/04 Nxera Pharma Co., Ltd. Initiates and Doses First Patient in Phase 2 Trial of Nbi-1117570 for Adults with Schizophrenia CI

MarketScreener Strategies

Search
See the results
Neurocrine's collaboration for pipeline and market expansionNeurocrine's collaboration for pipeline and market expansion November 25, 2025 at 05:49 pm IST
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NBIX Stock
  4. News Neurocrine Biosciences, Inc.
  5. MarketScreener Strategies

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

MarketScreener
United-States
MarketScreener Canada
Canada

MIDDLE EAST

MarketScreener Saudi Arabia
Saudi Arabia
MarketScreener UAE Emirates
United Arab Emirates

EUROPE

Zonebourse
France
MarketScreener Deutschland
Deutschland
Zonebourse Suisse
Suisse
MarketScreener Schweiz
Schweiz
MarketScreener Italia
Italia
MarketScreener Österreich
Österreich
MarketScreener België
België
MarketScreener Nederland
Nederland
MarketScreener España
España
MarketScreener Sverige
Sverige
MarketScreener UK
United Kingdom

APAC

MarketScreener Australia
Australia
MarketScreener India
India
MarketScreener Hong Kong
Hong Kong

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition